Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Chromatin immunoprecipitation (ChIP) Sequencing Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The global market for chromatin immunoprecipitation sequencing technology has experienced substantial expansion recently. Projections indicate a rise from $15.48 billion in 2025 to $17.42 billion by 2026, reflecting a projected compound annual growth rate (CAGR) of 12.5%. This projected growth trajectory is underpinned by several key factors that fueled its development during the preceding period, including the broadening scope of fundamental genomics studies, an increase in financial support for academic research endeavors, the widespread accessibility of advanced next-generation sequencing platforms, heightened scientific curiosity in the field of chromatin biology, and the proliferation of molecular biology laboratories.
The market for chromatin immunoprecipitation sequencing is poised for significant expansion, with projections indicating a rise to $29.02 billion by 2030, driven by a compound annual growth rate of 13.6%. This upward trajectory is fueled by a confluence of factors including heightened investment in epigenomics research, the escalating utilization of artificial intelligence in genomic analysis, the broadening scope of precision medicine, a greater need for multi-omics data integration, and the increasing reliance on cloud-based bioinformatics solutions. Key developments anticipated during this growth phase encompass a more widespread application of genome-wide protein-DNA interaction mapping, a surge in the adoption of high-throughput sequencing technologies, growing demand for tools that facilitate epigenetics research, the development of more comprehensive bioinformatics analysis pipelines, and an intensified focus on the study of regulatory genomics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp
#Chromatin immunoprecipitation (ChIP) Sequencing Market Demand Drivers Creating New Revenue Opportunities
The escalating incidence of prostate cancer is poised to stimulate expansion within the chromatin immunoprecipitation (ChIP) sequencing market. Prostate cancer, a malignancy originating in the prostate gland—a male reproductive organ responsible for seminal fluid production—is being increasingly studied using ChIP-seq. This advanced technique provides an exhaustive depiction of the molecular mechanisms underlying the disease’s progression. Such detailed insights are invaluable for advancing our comprehension of prostate cancer’s biological intricacies and for formulating more precise and impactful treatment strategies. As an illustration, data from the American Cancer Society, a prominent US cancer advocacy group, indicated that in 2023, the United States anticipated approximately 288,300 new diagnoses of prostate cancer and an estimated 34,700 fatalities attributed to the condition. Consequently, the heightened occurrence of prostate cancer is serving as a significant catalyst for the expansion of the ChIP sequencing market.
Chromatin immunoprecipitation (ChIP) Sequencing Market Segment Performance And Strategic Opportunities
The chromatin immunoprecipitation (chip) sequencing market covered in this report is segmented –
1) By Type: DNase-Sequencing, FAIRE-Sequencing
2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis
4) By Application: Consumables And Reagents, Service, Other Applications
5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users
Subsegments:
1) By DNase-Sequencing: DNase I Hypersensitivity Mapping, DNase-Seq For Open Chromatin Regions
2) By FAIRE-Sequencing: Formaldehyde-Assisted Isolation Of Regulatory Elements (FAIRE), FAIRE-Seq For Active Regulatory Regions
Chromatin immunoprecipitation (ChIP) Sequencing Market Trends Driving Strategic Industry Expansion
Key players within the chromatin immunoprecipitation (ChIP) sequencing market are directing their efforts toward pioneering technologies like hmqChIP-seq, which stands for high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing, with the aim of improving the precision and efficacy of epigenomic investigations, thereby propelling progress in areas such as drug development and tailored medical treatments. This sophisticated hmqChIP-seq technology is specifically engineered to elevate the examination of epigenetic changes across the entire genome. To illustrate, in June 2024, Epigenica, a Swedish entity specializing in life sciences technology, introduced its EpiFinder Platform, incorporating proprietary hmqChIP-seq capabilities. This platform facilitates quantitative epigenomic research on a large scale and in a multiplexed manner. The groundbreaking EpiFinder Platform empowers scientists to produce as many as 192 genome-wide profiles concurrently from a maximum of 24 distinct samples, consequently accelerating extensive research endeavors with remarkable speed and economic advantages.
Chromatin immunoprecipitation (ChIP) Sequencing Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the chromatin immunoprecipitation (chip) sequencing market are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.
Access The Complete Chromatin immunoprecipitation (ChIP) Sequencing Market Report:
Chromatin immunoprecipitation (ChIP) Sequencing Market Regional Distribution: Which Areas Drive Market Expansion?
North Americawas the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model